|Home | About | Journals | Submit | Contact Us | Français|
3-Ketosteroid-Δ1-dehydrogenase, KsdDM, was identified by targeted gene disruption and augmentation from Mycobacterium neoaurum NwIB-01, a newly isolated strain. The difficulty of separating 4-androstene-3,17-dione (AD) from 1,4-androstadiene-3,17-dione (ADD) is a key bottleneck to the microbial transformation of phytosterols in industry. This problem was tackled via genetic manipulation of the KsdD-encoding gene. Mutants in which KsdDM was inactivated or augmented proved to be good AD(D)-producing strains.
Steroid medications are widely used in clinical applications and are important in the pharmaceutical industry (5, 8). Among the steroidal derivatives, 4-androstene-3,17-dione (AD) and 1,4-androstadiene-3,17-dione (ADD) are two major products (3, 4). For industrial applications, microbial strains that can produce these chemicals are needed (9). To improve biotransformation, bacteria have been subjected to mutagenesis by UV/chemical treatments (10, 17, 18, 19, 21) and metabolic engineering (23, 24, 25, 27). However, most of the resulting strains produce AD and ADD simultaneously, which impedes their utility (11, 13).
Genes and pathways involved in phytosterol degradation have been identified in Rhodococcus and Mycobacterium species (1, 2, 6, 23, 24, 26). The enzyme that transforms AD to ADD is 3-ketosteroid-Δ1-dehydrogenase (KsdD) (4, 21) (Fig. (Fig.1).1). In this study, we identified the main gene encoding this enzyme in Mycobacterium neoaurum NwIB-01 (ksdDM) and manipulated it to develop AD(D)-producing strains. This is the first successful use of gene augmentation to increase production of ADD.
Using soybean phytosterols as the sole carbon source, strain NwIB-01 was isolated from steroid-contaminated soil samples and identified as Mycobacterium neoaurum (strain named Mycobacterium neoaurum NwIB-01) by 16S rRNA gene phylogenetic analysis and on the basis of its morphology. When cultured in fermentation medium containing 15 g/liter phytosterols for 96 h, NwIB-01 could produce 4.23 g/liter ADD and 1.76 g/liter AD simultaneously, showing it was a promising strain.
To obtain the genes involved in phytosterol degradation, the genomic fosmid library was built by using plasmid pCC2FOS, and fragments of the steroid degradation gene cluster, which is about 100 kb long and about 71% identical to the reported gene cluster in Mycobacterium tuberculosis (26), were selected using degenerate primers (7, 12, 16) (Table (Table1).1). The degenerate primers KsdD-SG-F/KsdD-SG-R, KshA-SG-F/KshA-SG-R, and KshB-SG-F/KshB-SG-R were used to amplify KsdD gene, 3-ketosteroid 9α-hydroxylase (KshA) gene, and KshB gene conserved sequences, respectively.
To identify the in vivo function of the ksdDM products, we disrupted ksdDM by double-crossover homologous recombination in NwIB-01 (15) (see Fig. S2 in the supplemental material). Inactivation of ksdDM (to create the NwIB-02 mutant) by the electrotransformation of suicide delivery vectors (pMN4) led to a significant change in the AD/ADD product ratio (see Fig. Fig.3b3b).
The open reading frame (ORF) of ksdDM (1,701 bp) uses GTG as the start codon with a possible ribosomal binding site (GAAAGG) 16 nucleotides upstream. Homology analysis revealed that KsdDM is 88% identical to the protein MSMEG5941 in Mycobacterium smegmatis (the highest homology found by comparing with GenBank). An unrooted phylogenetic tree was constructed using the PHYLIP program package (22) (Fig. (Fig.22 b), and the putative N-terminal flavin adenine dinucleotide (FAD)-binding motif in KsdDM was consistent with the sequence as previously described, GSG(A/G)(A/G)(A/G)X17E (24) (Fig. (Fig.2a2a).
The complete ksdDM gene was amplified by PCR with ksdDM-F/ksdDM-R primers. After digestion by NcoI/HindIII, the ksdDM gene was reclaimed and connected with the pET-22b(+) vector. After Ni-nitrilotriacetic acid purification, KsdDM (His6-tagged protein) activities were measured in triplicate spectrophotometrically at 30°C (25). The reaction mixture consisted of 50 mM Tris-HCl, pH 7.0, 1.5 mM phenazine methosulfate (PMS), 40 μM DCPIP (2,6-dichlorophenolindophenol), cell extract, and 200 mM AD in 2% methanol. Activities were expressed as mean values in mU (mg protein); 1 mU is defined as the reduction of 1 nM DCPIP min−1 (600 = 11.3 × 103 cm−1 M−1).
Our results indicated that by low-temperature induction (22°C), the recombinant protein appeared partly as the soluble protein, especially after 24 h (see Fig. S3 in the supplemental material). The KsdDM maximum activity of the intracellular soluble parts of KsdDM was 0.8 U/mg.
To overexpress ksdDM in Mycobacterium neoaurum, mycobacterial replicating vector pMV261 carrying the Mycobacterium bovis BCG Phsp60 promoter was used (20). The KsdDM gene was first amplified by PCR with AG-ksdDM-F/AG-ksdDM-R primers and cloned into the BamHI/HindIII sites of pMV261 (14). Augmentation of ksdDM (to create the NwIB-04 mutant) by the electrotransformation of shuttle plasmid pMV261- ksdDM led to a significant increase of ADD in the product ratio.
The mutants were first cultured in shaker flasks with 0.1 g/liter soybean phytosterols. Thin-layer chromatography (TLC) analysis revealed that NwIB-02 accumulated AD as the main product, while NwIB-04 accumulated ADD. Based on band intensity from TLC analysis, the AD/ADD molar yields with NwIB-02 were about 10:1 and 1:2 with wild-type NwIB-01 (Fig. (Fig.33 b). These results revealed that steroid-1-dehydrogenation activity was weakened by the KsdDM gene knockout and enhanced by KsdDM gene augmentation.
To further quantify the producing properties, the scaleup from flask to fermentor was performed. A 3.7-liter bioreactor (KLF2000; Bioengineering, Switzerland) was used during the batch stage. All fermentation experiments were carried out at 30°C and 300 rpm with airflow at 0.5 volumes of air per unit of medium per minute (vvm). After 24 h, soybean phytosterols (15 g/liter in 0.5% [vol/vol] Tween 80) were added to the medium and the bioconversion was monitored for several days. The production composition was quantified by high-pressure liquid chromatography (HPLC) with an Agilent XDB-C18 column (HPLC conditions: column temperature, 40°C; mobile phase, methanol-water [8.0:2.0]; flow rate, 1 ml/min.) (Fig. (Fig.4).4). For NwIB-01, the accumulation of AD(D) reached the maximum in 96 h after phytosterols (ADD, 4.23 g/liter; AD, 1.76 g/liter) were added. For strain NwIB-04, ADD reached the maximum 4.94 g/liter with only 0.096 g/liter AD (Table (Table2).2). The molar ratio of AD to ADD in products of strain NwIB-01 was 1:2.4, while it reached 11.5:1 in mutant NwIB-02 (data not shown in this paper) and 1:51.5 in mutant NwIB-04. Trace amounts of 9-OH-AD and substrate were also observed in our research and can be negligible for low 9-OH-AD and substrate contents. The final ADD purity was more than 95% after optimal fermentation conditions with NwIB-04. These results demonstrate that strain NwIB-04 is a successful ADD-producing strain.
In conclusion, the results presented above reveal that KsdDM, first obtained from M. neoaurum NwIB-01, serves as the main KsdD for steroid metabolism. This study provides a feasible way to achieve excellent phytosterol-transforming strains with high purity. KsdDM in M. neoaurum NwIB-01 could be rationally modified by the method of metabolic engineering to achieve improved strains with high AD(D) production purity, which implies that other Mycobacterium strains transforming phytosterols to AD(D) could be improved by the same methods.
The GenBank accession numbers for M. neoaurum NwIB-01 ksdDM, kshA, and kshB identified in this study are GQ228843.1, GQ476982.1, and GU363925, respectively.
We thank T. Parish (Department of Infectious & Tropical Diseases, United Kingdom) for providing plasmids p2NIL and pGOAL19 and W. R. Jacobs, Jr. (Howard Hughes Medical Institute), for providing plasmid pMV261.
This research was financially supported by the National Basic Research Program of China (no. 2009CB724703), the National High Technology Research and Development Program of China (no. 2008AA02Z209), and the National Special Fund for State Key Laboratory of Bioreactor Engineering, grant no. 2060204.
Published ahead of print on 7 May 2010.
†Supplemental material for this article may be found at http://aem.asm.org/.